HAE HAEMONETICS CORP Investments/Divestments 8-K Filing 2024 - Offer for Sale Haemonetics Corp intends to offer $525 million aggregate principal amount of convertible senior notes due 2029 in a private offering.Get access to all SEC 8-K filings of the HAEMONETICS CORP